An enzymatic pathway for synthesis of 5-phospho-D-ribosyl ␣-1-diphosphate (PRPP) without the participation of PRPP synthase was analyzed in Escherichia coli. This pathway was revealed by selection for suppression of the NAD requirement of strains with a deletion of the prs gene, the gene encoding PRPP synthase (B. Hove-Jensen, J. Bacteriol. 178:714-722, 1996). The new pathway requires three enzymes: phosphopentomutase, ribose 1-phosphokinase, and ribose 1,5-bisphosphokinase. The latter activity is encoded by phnN; the product of this gene is required for phosphonate degradation, but its enzymatic activity has not been determined previously. The reaction sequence is ribose 5-phosphate 3 ribose 1-phosphate 3 ribose 1,5-bisphosphate 3 PRPP. Alternatively, the synthesis of ribose 1-phosphate in the first step, catalyzed by phosphopentomutase, can proceed via phosphorolysis of a nucleoside, as follows: guanosine ؉ P i 3 guanine ؉ ribose 1-phosphate. The ribose 1,5-bisphosphokinase-catalyzed phosphorylation of ribose 1,5-bisphosphate is a novel reaction and represents the first assignment of a specific chemical reaction to a polypeptide required for cleavage of a carbon-phosphorus (COP) bond by a C-P lyase. The phnN gene was manipulated in vitro to encode a variant of ribose 1,5-bisphosphokinase with a tail consisting of six histidine residues at the carboxy-terminal end. PhnN was purified almost to homogeneity and characterized. The enzyme accepted ATP but not GTP as a phosphoryl donor, and it used ribose 1,5-bisphosphate but not ribose, ribose 1-phosphate, or ribose 5-phosphate as a phosphoryl acceptor. The identity of the reaction product as PRPP was confirmed by coupling the ribose 1,5-bisphosphokinase activity to the activity of xanthine phosphoribosyltransferase in the presence of xanthine, which resulted in the formation of 5-XMP, and by cochromatography of the reaction product with authentic PRPP.NAD biosynthesis in Escherichia coli usually proceeds by consumption of 5-phospho-D-ribosyl ␣-1-diphosphate (PRPP). NAD is synthesized from aspartate and dihydroxyacetone phosphate. A de novo pathway and a number of salvage pathways for the reutilization of nicotinamide mononucleotide and nicotinamide exist, as shown in Fig. 1 (32). Two of the enzymatic reactions, the reactions catalyzed by quinolinate and nicotinate phosphoribosyltransferases, require PRPP. PRPPless mutants with a deletion of the prs gene, encoding PRPP synthase, consequently require NAD or nicotinamide mononucleotide. ⌬prs strains also require guanosine, uridine, histidine, and tryptophan, which are likewise synthesized with PRPP as an intermediate (14,15). Nevertheless, mutants that suppress the NAD requirement are easily obtained by selecting for growth of ⌬prs cells on medium lacking NAD. These mutants still require guanosine, uridine, histidine, and tryptophan. All such NAD-suppressed mutants were previously shown to have lesions in the pst-phoU operon (17), which leads to highlevel constitutive expression of genes belonging to the phosphate (Ph...